| PUBCHEM ID |
91810537
|
| UNII |
R0A720567S
|
| Preferred Term |
21-CHLORO-9-FLUORO-11-HYDROXY-17-(1-OXOPROPOXY)PREGN-4-ENE-3,20-DIONE, (11.BETA.)-
|
| CAS |
78719-59-2
|
| INCHIKEY |
DLIZUDFEPOFWII-VTFYZQLFSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCC(O[C@](CC1)([C@@](C)(C[C@@H]2O)[C@@H]1[C@H](CCC([C@]1(C)CC3)=CC3=O)[C@@]12F)C(CCl)=O)=O
|
| Total Surface Area |
315,34
|
| Relative PSA |
0,19731
|
| TPSA |
80,67
|
| cLogS |
-4,906
|
| MW |
454,964
|
| cLogP |
3,3895
|
| H-Acceptors |
5
|
| H-Donors |
1
|
| Ro5 violations |
0
|
| Druglikeness |
2,0349
|
| DrugScore |
0,154617787234334
|
| Mutagenic |
low
|
| Tumorigenic |
high
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
0,9843
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,2213
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,3436
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,1614
|
| Carcinogenicity (Three-class) |
Non-required
|
